On this page
Referral and warning signs
When to refer
Referral to hospital (HC4/H/RR) / Specialist required for ALL suspected cases for diagnosis, ATT initiation, assessment for stability/neuro compromise, potential bracing/surgery.
Red flags
- Progressive neurological deficit
- Signs of spinal instability
- Significant kyphotic deformity
- Large cold abscess
- Failure to improve on ATT
Signs and symptoms
- Back pain: Insidious onset, localized, progressive.
- Constitutional symptoms: Fever (often low-grade), night sweats, weight loss, malaise (<40% cases).
- Muscle spasm and rigidity.
- Spinal tenderness.
- Visible deformity: Angular kyphosis (gibbus).
- Neurological deficits (Pott's Paraplegia): Leg weakness, sensory loss, bowel/bladder dysfunction.
- Paravertebral abscess / Cold abscess (may present as swelling elsewhere, e.g., psoas abscess).
Risk factors
- Living in or travelling from TB endemic areas.
- HIV co-infection (major risk factor).
- Immunosuppression (other causes).
- Malnutrition.
- Close contact with active pulmonary TB case.
Diagnosis
Clinical assessment
Suspect in patients from endemic areas with chronic back pain, +/- constitutional symptoms, +/- spinal deformity, +/- neurological deficits. Differentiate from pyogenic spondylodiscitis, brucellosis, fungal osteomyelitis, metastases, primary bone tumours.
Investigations
- Imaging: Plain X-ray (Spine) - may show late changes (disc space narrowing, vertebral destruction, paravertebral shadow, gibbus). MRI Scan (Spine) - Modality of choice (shows vertebral/disc involvement, abscesses, cord compression). CT Scan (Spine) - good for bony detail.
- Microbiological/Histological Confirmation: CT-guided Biopsy/Aspiration of vertebra/abscess - AFB smear, GeneXpert MTB/RIF, TB culture, Histology (caseating granulomas).
- Sputum AFB/Xpert: Check for concurrent pulmonary TB (~50%).
- Blood tests: ESR/CRP (often elevated).
- HIV testing.
- TST/IGRA: Indicate exposure/LTBI, not active disease.
Diagnostic criteria
Combination of clinical features, characteristic imaging findings (esp. MRI), and ideally microbiological/histological confirmation or strong evidence of TB elsewhere.
Management
Non-pharmacological management
- Spinal Immobilisation/Rest: Bed rest, spinal brace/corset/plaster jacket.
- Physiotherapy/Rehabilitation.
- Nutritional support.
- Surgical Intervention: Indications - Significant/progressive neurological deficit, Spinal instability, Large abscess needing drainage, Failure of medical therapy, Diagnostic uncertainty, Severe deformity.
Pharmacological treatment
- Anti-Tuberculosis Therapy (ATT): Mainstay. Standard multi-drug regimens, longer duration (9-12 months).
- - Standard Regimen (DS-TB): 2 months RHZE followed by 7-10 months RH.
- - Pyridoxine (B6) with Isoniazid.
- - Drug-Resistant Spinal TB: Specialized regimens.
- Analgesia (Paracetamol, NSAIDs, Opioids).
- Corticosteroids: Controversial, may be considered by specialists for cord compression due to inflammation.
Monitoring
Monitor clinical response (pain, neuro status). Monitor inflammatory markers. Periodic imaging. Monitor ATT side effects.
Complications
- Vertebral collapse / Kyphosis (Gibbus deformity)
- Spinal instability
- Neurological deficit / Paraplegia (Pott's paraplegia)
- Abscess formation (Paravertebral, Psoas, Cold)
- Sinus tract formation
- Chronic pain
- Secondary bacterial infection
Prevention
- BCG vaccination (limited protection).
- Early diagnosis/treatment of pulmonary TB.
- Treatment of latent TB infection (TPT).
Patient education
- Explain Pott's disease as TB of the spine.
- Necessity of prolonged ATT.
- Importance of adherence.
- Potential side effects of ATT.
- Role of bracing/rest.
- Symptoms of neurological worsening to report immediately.
- Importance of follow-up.
- Nutritional advice.
Uganda-specific notes
Significant form of EPTB, esp. with HIV. Diagnosis often delayed. Access to MRI/biopsy limited. Management relies on clinical/X-ray diagnosis and standard ATT (often 12 months). Surgical capacity restricted.
References
- Uganda Clinical Guidelines (UCG) 2023
Chapter 10, Section 10.1.4
- Uganda Clinical Guidelines (UCG) 2023
Chapter 5, Section 5.3 (General TB Treatment)
- Manual of the National TB/Leprosy Programme (NTLP) Uganda
(Refer to latest NTLP guidelines)